Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.880 | 4.000 | 0.120 |
Stocks | 96.120 | 96.120 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.537 | 14.472 |
Price to Book | 2.955 | 2.115 |
Price to Sales | 1.785 | 1.663 |
Price to Cash Flow | 13.001 | 11.764 |
Dividend Yield | 2.580 | 2.773 |
5 Years Earnings Growth | 5.244 | 8.714 |
Name | Net % | Category Average |
---|---|---|
Industrials | 55.690 | 40.026 |
Financial Services | 12.040 | 20.805 |
Healthcare | 9.240 | 9.640 |
Consumer Defensive | 8.470 | 4.528 |
Technology | 8.080 | 8.372 |
Consumer Cyclical | 6.490 | 6.420 |
Number of long holdings: 34
Number of short holdings: 9
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Volvo B | SE0000115446 | 8.33 | 271.10 | -0.48% | |
Atlas Copco A | SE0017486889 | 6.59 | 202.3 | -0.69% | |
Hexagon B | SE0015961909 | 6.08 | 116.65 | +0.11% | |
SEB A | SE0000148884 | 5.93 | 151.40 | +0.20% | |
ASSA ABLOY B | SE0007100581 | 5.84 | 309.9 | +0.36% | |
AstraZeneca | GB0009895292 | 5.55 | 12,376.0 | -1.78% | |
Essity B | SE0009922164 | 4.97 | 280.40 | +0.50% | |
ABB | CH0012221716 | 4.88 | 50.10 | -0.52% | |
Sandvik AB | SE0000667891 | 4.61 | 219.80 | -0.86% | |
Epiroc A | SE0015658109 | 3.93 | 214.10 | -0.88% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SE0011309707 | 115.09B | 12.77 | 12.08 | 13.26 | ||
SE0010127894 | 54.27B | 15.95 | 9.89 | - | ||
Handelsbanken Global Tema (B1 SEK) | 42.62B | 14.78 | 10.19 | - | ||
Handelsbanken Global Tema (A1 SEK) | 42.62B | 14.78 | 10.19 | 13.39 | ||
Handelsbanken Multi Asset 50 A1 S | 32.21B | 7.90 | 4.23 | 5.91 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review